Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 - 24/08/11

Doi : 10.1016/j.jaci.2003.12.591

S.G.O Johansson, MD, PhD ^a,^⁎ , Thomas Bieber, MD ^b, Ronald Dahl, MD ^c, Peter S Friedmann, MD ^d, Bobby Q Lanier, MD ^e, Richard F Lockey, MD ^f, Cassim Motala, MD ^g, Jose A Ortega Martell, MD ^h, Thomas A.E Platts-Mills, MD ⁱ, Johannes Ring, MD ^j, Frank Thien, MD ^k, Paul Van Cauwenberge, MD ^l, Hywel C Williams, MD ^m
From ^athe Department of Medicine, Unit of Clinical Immunology and Allergy, Karolinska University Hospital, Stockholm, Sweden; ^bthe Department of Dermatology, Friedrich-Wilhelms University, Bonn, Germany; ^cthe Department of Respiratory Disease and Allergology, Aarhus University Hospital, Aarhus, Denmark; ^dthe Dermatopharmacology Unit, Southampton General Hospital, Southampton, United Kingdom; ^ethe Department of Pediatrics, University of North Texas Health Science Center, Fort Worth, Tex, and representative of the American College of Allergy, Asthma and Immunology; ^fthe Division of Allergy and Immunology, University of South Florida College of Medicine and James A. Haley Veterans Hospital, Tampa, Fla; ^gRed Cross Children's Hospital, Rondebosch, Cape Town, South Africa; ^hCollegio de Pediatria de Hidalgo, Mexico City, Mexico, and representative of the Latin American Society of Allergy and Immunology; ⁱAsthma and Allergic Diseases Center, University of Virginia Medical Center, Charlottesville, Va, and representative of the American Academy of Allergy, Asthma and Immunology; ^jZentrum Allergie und Umwelt GSF/TUM, Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany; ^kthe Department of Medicine, Monash University, Melbourne, Australia, and representative of the Asia Pacific Association of Allergology and Clinical Immunology; ^lthe Department of Oto-Rhino-Laryngology, University Hospital, Ghent, Belgium, and representative of the European Academy of Allergology and Clinical Immunology; and the ^mCentre of Evidence Based Dermatology, Queen's Medical Centre, Nottingham, United Kingdom

Reprint requests: S. G. O. Johansson, MD, Department of Clinical Immunology, Karolinska University Hospital, L2:04, S-171 76 Stockholm, Sweden

Fort Worth, Tex, Tampa, Fla, Charlottesville, Va, Stockholm, Sweden, Bonn and Munich, Germany, Aarhus, Denmark, Southampton and Nottingham, United Kingdom, Cape Town, South Africa, Mexico City, Mexico, Melbourne, Australia, and Ghent, Belgium

Abstract

The nomenclature proposed in the October 2003 report of the Nomenclature Review Committee of the World Allergy Organization is an update of the European Academy of Allergology and Clinical Immunology Revised Nomenclature for Allergy Position Statement published in 2001. The nomenclature can be used independently of target organ or patient age group and is based on the mechanisms that initiate and mediate allergic reactions. It is assumed that as knowledge about basic causes and mechanisms improves, the nomenclature will need further review.

Le texte complet de cet article est disponible en PDF.

Keywords : Nomenclature, allergy, hypersensitivity, IgE, atopy, asthma, dermatitis, eczema, rhinitis, anaphylaxis

Abbreviations : EAACI, NPS, WAO